Telmisartan and hydrochlorothiazide antihypertensive treatment in high sodium intake population: a randomized double-blind trial

Journal of Hypertension
Puhong ZhangNingling Sun

Abstract

To compare the blood pressure (BP)-lowering effects of telmisartan 40 mg/day and hydrochlorothiazide (HCTZ) 25 mg/day in high sodium intake patients with mild-to-moderate hypertension in China. In this randomized, double-blind trial, eligible patients were randomly divided into telmisartan and HCTZ groups with three follow-ups scheduled on days 15, 30, and 60 after enrollment to compare BP decrease, hypokalemia, and other adverse events after intervention. A total of 1333 mild-to-moderate hypertensive patients with average sodium intake of 5909 mg/day were enrolled from 14 county hospitals in China. Baseline characteristics were well balanced. At 15, 30, and 60 days of follow-up, average SBP/DBP reduction in telmisartan and HCTZ group was 12.5/8.0, 14.3/9.1, 12.8/7.2, 11.0/5.8, 13.6/7.1, and 11.5/5.3 mmHg, respectively. Telmisartan showed greater BP response than HCTZ at three visits, with statistical significance for DBP (P < 0.001) regardless of the adjustment for baseline BP, sodium excretion, and pulse pressure (PP). SBP reduction was positively related to increasing urinary sodium and PP levels for patients in both groups but increased faster with increasing PP in HCTZ than in telmisartan (P = 0.0238 for group × PP). Compa...Continue Reading

References

Feb 15, 2001·Circulation·M Burnier
Jan 10, 2006·Drugs·Anna J Battershill, Lesley J Scott
Jul 17, 2008·Nature Clinical Practice. Cardiovascular Medicine·Theodore W Kurtz
May 1, 2010·Journal of the American Dietetic Association·Cheryl A M AndersonJeremiah Stamler
Jun 10, 2010·Expert Review of Cardiovascular Therapy·Julio D Duarte, Rhonda M Cooper-DeHoff
Sep 5, 2014·Journal of Hypertension·Nagako OkudaUNKNOWN INTERMAP Research Group
Jan 23, 2015·Journal of Integrative Medicine·Vamsi ReddyJiwang Chen
May 1, 2015·American Journal of Hypertension·Peng ChenDao Wen Wang
May 27, 2015·American Journal of Hypertension·Weizhong HanZhiyi Ma
Jun 8, 2015·Current Opinion in Cardiology·Wanpen Vongpatanasin
Apr 7, 2016·American Journal of Hypertension·George C Roush, Domenic A Sica

❮ Previous
Next ❯

Citations

Mar 12, 2020·Journal of General Internal Medicine·Jill J HallJohn-Michael Gamble

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.